Recent data obtained by Vyas et al. in ovarian cancer patients, a type of cancer with a pro-inflammatory signature similar to HCC, demonstrated that high levels of soluble MICA and ULBP2 were associated with poor prognosis. Here, MICA is linked to ovarian carcinoma.